Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Minimal relapse risk and early normalization of survival for patients with Burkitt lymphoma treated with intensive immunochemotherapy: an international study of 264 real‐world patients

British Journal of Haematology(2020)10.1111/bjh.16425Source: DataRank Database

Minimal relapse risk and early normalization of survival for patients with Burkitt lymphoma treated with intensive immunochemotherapy: an international study of 264 real‐world patients is a research paper published in British Journal of Haematology (2020). On theSindex it has a DataRank of 0. It has been cited 23 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access23 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 1.46)OA: bronzeTopics (27)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (24)

Fredrik Ellin ORCID,Knut B. Smeland ORCID,Tove Wästerlid ORCID,Jacob Haaber Christensen,Judit Jørgensen

Live enrichment

PubMed:32017050 OpenAlex:https://openalex.org/W3004936895

Kræftens Bekæmpelse

National Institutes of Health

FWCI

1.46

Citation Percentile

0.8%

Citation Trend

2020

2021

2022

2024

2025

2026

bronzeLicense: http://onlinelibrary.wiley.com/termsAndConditions#vor

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjh.16425

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjh.16425

publisherhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fbjh.16425

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.16425

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1111/bjh.16425

Fields of Study

Lymphoma Diagnosis and TreatmentCNS Lymphoma Diagnosis and TreatmentViral-associated cancers and disorders

MeSH Terms

AdolescentAdultAgedAged, 80 and overBurkitt LymphomaFemaleHumansMaleMiddle AgedRetrospective StudiesSurvival AnalysisTreatment OutcomeYoung Adult

Keywords

MedicineLymphomaBurkitt's lymphomaInternal medicineNormalization (sociology)OncologySurvivalPrognosisBurkitt LymphomaImmunochemotherapyReal-world Patients

Sustainable Development Goals

SDG 0: Partnerships for the goals